Self-administered nasal flu vaccine
FDA approves first flu vaccine that can be self-administered at home
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.
Nasal spray flu vaccine approved for home use: Here’s what to know
The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company and Covid vaccine-maker AstraZeneca, was announced last week and can be used by adults aged 49 and under.
At-home nasal spray flu vaccine coming next year
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and Drug Administration expanded its approval of AstraZeneca's FluMist. Why it matters: It will be the first flu vaccine that doesn't need to be administered by a health provider and will be sold direct to consumers for home use via an online pharmacy.
US FDA approves AstraZeneca's flu vaccine for self-administration
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for self-administration, making it the first of its kind that patients can give themselves.
With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on AstraZeneca's influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17.
First self-administered, at-home flu vaccine receives FDA approval
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first self-administered flu vaccine that can be taken right at home.
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
An At-Home Nasal Flu Vaccine Is Coming Next Year
I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That process is about to get even easier: the FDA has approved the first flu vaccine that you can administer yourself,
At-home flu vaccine approved by FDA — what to know
People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can administer it themselves.
Physician answers questions about first at-home flu vaccine
The U.S. Food and Drug Administration has approved the first at-home flu vaccine that people can self-administer.
Inside Your Health: Self-administered nasal flu vaccine
To help increase vaccination rates, the FDA just approved a new flu vaccine that people will be able to give themselves at home. This new option will be available for next year’s flu season. 5 EYEWITNESS NEWS anchor Leah McLean sat down with KSTP health expert Dr.
The Financial Express16h
AstraZeneca’s FluMist approval for self-administration could increase flu vaccine uptake: GlobalData
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...
News Nation on MSN4d
FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
KSL7d
FDA approves flu vaccine that can be self-administered at home
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
The Financial Express16h
AstraZeneca’s FluMist approval for self-administration could increase flu vaccine uptake
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...